Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells.
- Published in:
- Immunologic Research, 2019, v. 67, n. 6, p. 497, doi. 10.1007/s12026-019-09111-w
- By:
- Publication type:
- Article
Works matching IS 0257277X AND DT 2019 AND VI 67 AND IP 6
Results: 6
1
2
Autoantibodies against P29ING4 are associated with complex regional pain syndrome.
- Published in:
- Immunologic Research, 2019, v. 67, n. 6, p. 461, doi. 10.1007/s12026-020-09114-y
- By:
- Publication type:
- Article
3
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.
- Published in:
- Immunologic Research, 2019, v. 67, n. 6, p. 505, doi. 10.1007/s12026-019-09113-8
- By:
- Publication type:
- Article
4
CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
- Published in:
- Immunologic Research, 2019, v. 67, n. 6, p. 486, doi. 10.1007/s12026-019-09112-9
- By:
- Publication type:
- Article
5
A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome.
- Published in:
- Immunologic Research, 2019, v. 67, n. 6, p. 478, doi. 10.1007/s12026-019-09110-x
- By:
- Publication type:
- Article
6
Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer.
- Published in:
- Immunologic Research, 2019, v. 67, n. 6, p. 469, doi. 10.1007/s12026-019-09109-4
- By:
- Publication type:
- Article